Cargando…

Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications

Pyroptosis is a kind of programmed cell death closely related to inflammation. The pathways that mediate pyroptosis can be divided into the Caspase-1-dependent canonical pathway and the Caspase4/5/11-dependent non-canonical pathway. The most significant difference from other cell death is that pyrop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Ruoning, Xue, Wenjing, Shi, Shuqing, Zhou, Yu, Du, Yihang, Li, Yuan, Song, Qingqiao, Wu, Huaqin, Hu, Yuanhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058112/ https://www.ncbi.nlm.nih.gov/pubmed/35509275 http://dx.doi.org/10.3389/fcvm.2022.870924

Ejemplares similares

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
por: Shi, Shuqing, et al.
Publicado: (2022)

Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction
por: Chai, Ruoning, et al.
Publicado: (2023)

Circadian rhythm in cardiovascular diseases: a bibliometric analysis of the past, present, and future
por: Chai, Ruoning, et al.
Publicado: (2023)

Trends in mitochondrial unfolded protein response research from 2004 to 2022: A bibliometric analysis
por: Ye, Zelin, et al.
Publicado: (2023)

Role of resveratrol in inhibiting pathological cardiac remodeling
por: Fan, Shaowei, et al.
Publicado: (2022)

Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021
por: You, Yaping, et al.
Publicado: (2022)

Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure
por: Wang, Yajiao, et al.
Publicado: (2023)

The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022
por: Xu, Xia, et al.
Publicado: (2022)

Mitochondrial dysfunction in heart failure and its therapeutic implications
por: Liu, Miaosen, et al.
Publicado: (2022)

The Role of Myocardial Mitochondrial Quality Control in Heart Failure
por: Qiu, Zhiling, et al.
Publicado: (2019)

Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure
por: Berezin, Alexander E., et al.
Publicado: (2020)

Role of m6A Methylation in the Occurrence and Development of Heart Failure
por: Fan, Shaowei, et al.
Publicado: (2022)

Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair
por: Huang, Huai, et al.
Publicado: (2022)

Knowledge domain and emerging trends in empagliflozin for heart failure: A bibliometric and visualized analysis
por: Zhang, Xuesong, et al.
Publicado: (2022)

The Discriminatory Ability of Renalase and Biomarkers of Cardiac Remodeling for the Prediction of Ischemia in Chronic Heart Failure Patients With the Regard to the Ejection Fraction
por: Stojanovic, Dijana, et al.
Publicado: (2021)

Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020
por: Yuan, Guozhen, et al.
Publicado: (2021)

A Porcine Model of Heart Failure With Preserved Ejection Fraction Induced by Chronic Pressure Overload Characterized by Cardiac Fibrosis and Remodeling
por: Tan, Weijiang, et al.
Publicado: (2021)

Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis
por: Li, Yumeng, et al.
Publicado: (2021)

A time-series minimally invasive transverse aortic constriction mouse model for pressure overload-induced cardiac remodeling and heart failure
por: Wang, Xia, et al.
Publicado: (2023)

Circle the Cardiac Remodeling With circRNAs
por: Yang, Tiqun, et al.
Publicado: (2021)

Mitochondrial Metabolism in Myocardial Remodeling and Mechanical Unloading: Implications for Ischemic Heart Disease
por: Jiang, Min, et al.
Publicado: (2021)

Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023)

Ubiquitin Carboxyl-Terminal Hydrolase L1 of Cardiomyocytes Promotes Macroautophagy and Proteostasis and Protects Against Post-myocardial Infarction Cardiac Remodeling and Heart Failure
por: Wu, Penglong, et al.
Publicado: (2022)

Editorial: Advances in cardiac imaging and heart failure management
por: Mandoli, Giulia Elena, et al.
Publicado: (2023)

The interstitial compartment as a therapeutic target in heart failure
por: Aronson, Doron
Publicado: (2022)

A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failure
por: Wang, Zhenya, et al.
Publicado: (2023)

MCC950, a Selective NLRP3 Inhibitor, Attenuates Adverse Cardiac Remodeling Following Heart Failure Through Improving the Cardiometabolic Dysfunction in Obese Mice
por: Wang, Menglong, et al.
Publicado: (2022)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
por: Gogiraju, Rajinikanth, et al.
Publicado: (2019)

The Future of Exercise-Based Cardiac Rehabilitation for Patients With Heart Failure
por: Passantino, Andrea, et al.
Publicado: (2021)

Roles of histone acetylation sites in cardiac hypertrophy and heart failure
por: Funamoto, Masafumi, et al.
Publicado: (2023)

Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials
por: Zhao, Jin-Dong, et al.
Publicado: (2018)

Is there a role for combination anti-remodelling therapy for heart failure secondary to chronic rheumatic mitral regurgitation?
por: Meel, Ruchika, et al.
Publicado: (2017)

Insights on Distinct Left Atrial Remodeling Between Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction
por: Kuo, Jen-Yuan, et al.
Publicado: (2022)

Heart failure in systemic right ventricle: Mechanisms and therapeutic options
por: Sabbah, Belal Nedal, et al.
Publicado: (2023)

Transgenic Expression of miR-133a in the Diabetic Akita Heart Prevents Cardiac Remodeling and Cardiomyopathy
por: Kambis, Tyler N., et al.
Publicado: (2019)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Tracing triggers of cardiac remodelling and heart failure
por: van Driel, B. O., et al.
Publicado: (2021)

MicroRNA-Related Strategies to Improve Cardiac Function in Heart Failure
por: Zhou, Huatao, et al.
Publicado: (2021)

Corin deficiency impairs cardiac function in mouse models of heart failure
por: Niu, Yayan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_43oapvsi4j79r3421oq1pb0fqm